{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T10:38:19Z","timestamp":1785494299009,"version":"3.56.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["psy-journal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.psychres.2015.11.013","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T22:30:55Z","timestamp":1447194655000},"page":"160-168","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Use of psychiatric medications in schizophrenia and other psychoses in a general population sample"],"prefix":"10.1016","volume":"235","author":[{"given":"Salla","family":"Nyk\u00e4nen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virpi","family":"Puska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussi-Pekka","family":"Tolonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Salo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Isohanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannu","family":"Koponen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Pirkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Penttil\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Haapea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jani","family":"Moilanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jouko","family":"Miettunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"J\u00e4\u00e4skel\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2015.11.013_bib1","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia","volume":"161","author":"American Psychiatric Association","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2015.11.013_bib2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","article-title":"Remission in schizophrenia: proposed criteria and rationale for consensus","volume":"162","author":"Andreasen","year":"2005","journal-title":"Am. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.psychres.2015.11.013_bib3","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2165\/11595380-000000000-00000","article-title":"Pharmacogenetics of response to antipsychotics in patients with schizophrenia","volume":"25","author":"Arranz","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2015.11.013_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eurpsy.2007.09.008","article-title":"The Schizophrenia Outpatient Health Outcomes (SOHO) study: 3-year results of antipsychotic treatment discontinuation and related clinical factors in Spain","volume":"23","author":"Ciudad","year":"2008","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.psychres.2015.11.013_bib6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1192\/bjp.187.3.248","article-title":"Schizophrenia practice guidelines: international survey and comparison","volume":"187","author":"Gaebel","year":"2005","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2015.11.013_bib7","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1017\/S0033291714000610","article-title":"Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study","volume":"44","author":"Harrow","year":"2014","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2015.11.013_bib8","series-title":"Recovery from Schizophrenia: An International Perspective: A Report from the WHO Collaborative Project, the International Study of Schizophrenia","author":"Hopper","year":"2007"},{"issue":"1\u20133","key":"10.1016\/j.psychres.2015.11.013_bib9","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.schres.2014.06.035","article-title":"Lifetime use of antipsychotic medication and its relation to change of verbal learning and memory in midlife schizophrenia \u2013 an observational 9-year follow-up study","volume":"158","author":"Husa","year":"2014","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2015.11.013_bib10","series-title":"IBM SPSS Statistics for Windows, Version 21.0","author":"IBM Corp. Released","year":"2012"},{"key":"10.1016\/j.psychres.2015.11.013_bib11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00789044","article-title":"A comparison of clinical and research DSM-III-R diagnoses of schizophrenia in a Finnish national birth cohort. Clinical and research diagnoses of schizophrenia","volume":"32","author":"Isohanni","year":"1997","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.psychres.2015.11.013_bib12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.psychres.2010.10.027","article-title":"Use of antipsychotics \u2013 an analysis of lifetime treatment in 66 patients with psychoses","volume":"187","author":"J\u00f6nsson","year":"2011","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2015.11.013_bib13","series-title":"Positive and Negative Syndrome Scale (PANSS), in: American Psychiatric Association, Handbook of Psychiatric Measures","first-page":"734","author":"Kay","year":"2000"},{"key":"10.1016\/j.psychres.2015.11.013_bib14","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/ijcp.12226","article-title":"The characteristics and outcomes of hospitalised and outpatient-treated first-onset schizophrenia patients: a 5-year register linkage study","volume":"67","author":"Kiviniemi","year":"2013","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.psychres.2015.11.013_bib15","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.schres.2013.07.043","article-title":"Antipsychotics and mortality in first-onset schizophrenia: prospective Finnish register study with 5-year follow-up","volume":"150","author":"Kiviniemi","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2015.11.013_bib16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-244X-9-24","article-title":"Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study","volume":"9","author":"Kroken","year":"2009","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.psychres.2015.11.013_bib17","first-page":"CD008016","article-title":"Maintenance treatment with antipsychotic drugs for schizophrenia","volume":"5","author":"Leucht","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.psychres.2015.11.013_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.eurpsy.2011.06.009","article-title":"Characteristics of subjects with schizophrenia spectrum disorder with and without antipsychotic medication \u2013 a ten-year follow-up of the Northern Finland 1966 Birth Cohort study","volume":"28","author":"Moilanen","year":"2013","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.psychres.2015.11.013_bib19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00127-003-0638-z","article-title":"Reasons for the diagnostic discordance between clinicians and researchers in schizophrenia in the Northern Finland 1966 Birth Cohort","volume":"38","author":"Moilanen","year":"2003","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.psychres.2015.11.013_bib20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/pds.2166","article-title":"Prescription patterns of patients diagnosed with schizophrenia in mental hospitals in Tashkent\/Uzbekistan and in four German cities","volume":"21","author":"Mundt","year":"2012","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.psychres.2015.11.013_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archpsyc.64.1.19","article-title":"Lifetime prevalence of psychotic and bipolar I disorders in a general population","volume":"64","author":"Per\u00e4l\u00e4","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2015.11.013_bib22","series-title":"Handbook of Psychiatric Measures","article-title":"Global Assessment Scale (GAS), Global Assessment of Functioning (GAF) scale, Social and Occupational Functioning Assessment Scale (SOFAS)","author":"Spitzer","year":"2000"},{"key":"10.1016\/j.psychres.2015.11.013_bib23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00127-012-0586-6","article-title":"Description of long-term polypharmacy among schizophrenia outpatients","volume":"48","author":"Suokas","year":"2013","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"issue":"9690","key":"10.1016\/j.psychres.2015.11.013_bib24","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(09)60742-X","article-title":"11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)","volume":"374","author":"Tiihonen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2015.11.013_bib25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/archgenpsychiatry.2011.1532","article-title":"Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia","volume":"69","author":"Tiihonen","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2015.11.013_bib26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.psychres.2006.09.016","article-title":"Gender differences in response to antipsychotic treatment in outpatients with schizophrenia","volume":"153","author":"Usall","year":"2007","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2015.11.013_bib27","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.schres.2006.03.021","article-title":"The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model","volume":"85","author":"van der Gaag","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2015.11.013_bib28","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/hup.1209","article-title":"Concomitant medication of psychoses in a lifetime perspective","volume":"26","author":"Vares","year":"2011","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"issue":"9","key":"10.1016\/j.psychres.2015.11.013_bib29","doi-asserted-by":"crossref","first-page":"e101689","DOI":"10.1371\/journal.pone.0101689","article-title":"Longitudinal changes in total brain volume in schizophrenia: relation to symptom severity, cognition and antipsychotic medication","volume":"18","author":"Veijola","year":"2014","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.psychres.2015.11.013_bib30","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1192\/bjp.168.4.520b","article-title":"Low incidence of mania in northern Finland","volume":"168","author":"Veijola","year":"1996","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2015.11.013_bib31","series-title":"Textbook in Psychiatric Epidemiology","first-page":"155","article-title":"The pharmacoepidemiology of psychiatric medications","author":"Wang","year":"2011"},{"key":"10.1016\/j.psychres.2015.11.013_bib32","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1177\/0004867412450471","article-title":"Medication for psychosis \u2013 consumption and consequences: the second Australian national survey of psychosis","volume":"46","author":"Waterreus","year":"2012","journal-title":"Aust. N.Z. J. Psychiatry"},{"key":"10.1016\/j.psychres.2015.11.013_bib33","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology (2010) Guidelines for ATC classification and DDD assignment 2011. Oslo, 2010"},{"key":"10.1016\/j.psychres.2015.11.013_bib34","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jamapsychiatry.2013.19","article-title":"Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction\/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial","volume":"70","author":"Wunderink","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2015.11.013_bib35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-2007-970062","article-title":"Clinical and social determinants of antipsychotic polypharmacy for Chinese patients with schizophrenia","volume":"40","author":"Xiang","year":"2007","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2015.11.013_bib36","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s11684-013-0249-3","article-title":"Pharmacogenetics can improve antipsychotic treatment in schizophrenia","volume":"7","author":"Xu","year":"2013","journal-title":"Front. Med."},{"key":"10.1016\/j.psychres.2015.11.013_bib37","series-title":"Working group set up by the Finnish Medical Society Duodecim and the Finnish Psychiatric Association","author":"Schizophrenia (online). Current Care Guidelines","year":"2014"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178115306545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178115306545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T20:55:04Z","timestamp":1537217704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178115306545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":36,"alternative-id":["S0165178115306545"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2015.11.013","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of psychiatric medications in schizophrenia and other psychoses in a general population sample","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2015.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}